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Aims:We investigated the effects of in vivo intrastriatal administration of glycine (Gly), which is found at high
concentrations in the brain of patients affected by nonketotic hyperglycinemia (NKH), on important
parameters of oxidative stress.
Main methods: Thiobarbituric acid-reactive substances values (TBA-RS, lipid peroxidation), carbonyl
formation (protein oxidative damage), sulfhydryl content, reduced glutathione concentrations, nitric oxide
production and the activities of the antioxidant enzymes glutathione peroxidase, glutathione reductase,
catalase, superoxide dismutase and glucose-6-phosphate dehydrogenase (antioxidant defenses) were
measured in striatum from 30-day-old rats after Gly injection.
Key ﬁndings: Gly administration signiﬁcantly increased TBA-RS values, implying lipid oxidative damage.
Furthermore, Gly-induced increase of TBA-RS was fully prevented by the NMDA receptor antagonist MK-801,
indicating the involvement of the NMDA glutamate receptor in this effect. Gly injection also induced protein
carbonyl formation, as well as elevation of the activities of glutathione peroxidase, glutathione reductase,
catalase and superoxide dismutase. In contrast, glutathione levels, sulfhydryl content, nitric oxide production
and the activity of glucose-6-phosphate dehydrogenase were not modiﬁed by Gly.
Signiﬁcance: The data shows that Gly in vivo administration causes lipid peroxidation, probably secondary to
NMDA stimulation, induces protein oxidation and modulates the activities of important antioxidant enzymes
in the striatum. In case these ﬁndings can be extrapolated to the human NKH, it is feasible that oxidative stress
may be involved in the pathophysiology of the brain injury observed in patients with this neurometabolic
disease.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Nonketotic hyperglycinemia (NKH) is an inborn error of glycine
(Gly) metabolism caused by a defect in Gly cleavage. Patients affected
by this disease have severe neurological symptoms with brain
abnormalities, as well as hypotonia and crises with apnea (Hamosh
and Johnston, 2001). Cerebral MRI ﬁndings include progressive
cortical atrophy, abnormalities in the putamen and decreased or
absentmyelination in thewhitematter (Press et al., 1989;Wintermark
et al., 2004; Shan, 2005; Cherian et al., 2009). The disorder presents a
prevalence estimated in 1:60,000 newborns (Applegarth et al., 2000).
The diagnosis of NKH is based on the ﬁnding of a raised cerebrospinaluímica, Instituto de Ciências
o Sul. Rua Ramiro Barcelos N°
.: +55 51 3308 5571; fax: +55
sevier OA license.ﬂuid-to-plasma-Gly ratio. Proton magnetic resonance spectroscopy
has revealed that brain Gly concentrations may be as high as 7.3 mM
with an average of 4.0 to 4.8 mM in NKH patients (Hamosh and
Johnston, 2001). Such increases are harmless in blood, but can cause
extensive neuronal damage in the neonatal brain (Applegarth and
Toone, 2001). NKH variants are the classical neonatal form and the late
onset type according to the period of onset of the symptoms. The
neonatal form of the disease is mostly lethal, and patients that survive
in the neonate period exhibit severe mental retardation and
intractable seizures. Although milder, patients affected by the late
onset form of the disorder also present neurological abnormalities.
Early treatment consisting of sodiumbenzoate and dextromethorphan
administrationmay improve the neurological sequel of these patients,
but is usually not very successful (Korman et al., 2006).
It is long recognized that catabolic stress in NKH results in
increased tissue Gly concentrations, leading to worsening of signs.
Furthermore, the higher the cerebrospinal ﬂuid (CSF)/plasma ratio,
the more severe is the clinical phenotype of the disease (Hamosh and
277B. Seminotti et al. / Life Sciences 89 (2011) 276–281Johnston, 2001). Therefore, it is likely that high Gly concentrations are
toxic to the brain and are possibly involved in the pathophysiology of
the characteristic leukoencephalopathy present in this disease, but
this is so far not yet proven.
It has been postulated that excitotoxicity may be involved in the
neurological damage found in patients affected by NKH, since Gly acts
as a co-agonist on N-methyl-D-aspartate glutamate (NMDA) receptor,
enhancing excitotoxic events related to glutamate neurotransmission
(McNamara and Dingledine, 1990; Patel et al., 1990; Hara et al., 1993;
Kure et al., 1997; Katsuki et al., 2007; Kono et al., 2007). In addition, it
was recently demonstrated that Gly induces oxidative damage, reduces
the antioxidant defenses (Leipnitz et al., 2009) and compromises
bioenergetics in brain of rats (Busanello et al., 2010) in vitro, but Gly
deleterious effects in vivo and the exact pathomechanisms involved are
still not established. Therefore, in the present studywe investigated the
inﬂuence of in vivo Gly intrastriatal administration on important
parameters of oxidative stress, namely thiobarbituric acid-reactive
substances (TBA-RS), sulfhydryl oxidation, reduced glutathione (GSH)
levels, protein carbonyl content, nitric oxide production and the
activities of the antioxidant enzymes glutathione peroxidase (GPx),
glutathione reductase (GR), catalase (CAT), superoxide dismutase
(SOD) and glucose-6-phosphate dehydrogenase (G6PD) in striatum of
young rats.Wealso examined the role of aNMDA-receptor antagonist to
clarify the mechanisms involved in the oxidative damage induced by
intrastriatal Gly injection.
Experimental procedures
Animals and reagents
Thirty-day-old Wistar rats, obtained from the Central Animal
House of the Department of Biochemistry, ICBS, Universidade Federal
do Rio Grande do Sul, Porto Alegre, RS, Brazil, were used. The animals
were maintained on a 12:12 h light/dark cycle (lights on 07.00–
19.00 h) in air conditioned constant temperature (22±1 °C) colony
room, with free access to water and 20% (w/w) protein commercial
chow (SUPRA, Porto Alegre, RS, Brazil). All reagents used were of
analytical grade and purchased from Sigma Co. (St Louis, MO, USA),
except for dizocilpine maleate (MK-801), which was purchased from
Tocris (Ballwin, MO, USA).
Glycine (Gly) administration
The rats were deeply anesthetizedwith equitesine (3.33 mL/Kg i.p.),
which is amixture of 0.25 M chloral hydrate, 88 mMmagnesiumsulfate
heptahydrate, 10 mg/mL sodium tiopenthal, 5.8 Mpropylene glycol and
1.97 M ethanol, and thereafter placed in a stereotaxic apparatus. Two
small holes were drilled in the skull and 1 μL of a 4 M Gly solution
(4 μmol) orNaCl (controls) at the samevolume and concentration (each
solution was prepared in water and pHwas adjusted to 7.4 with NaOH)
was slowly injected bilaterally into each striatum over 3 min via a
needle connected by a polyethylene tube to a 10 μL Hamilton syringe.
The needle was left in place for another 1 min before being gently
removed, so that the total procedure lasted 4 min. The coordinates for
injections were as follows: 0.6 mm posterior to the bregma, 2.6 mm
lateral to the midline and 4.5 mm ventral from dura (Paxinos and
Watson, 1986). The correct position of the needle was tested by
injecting 0.5 μL of methylene blue injection (4% in saline solution) and
carrying out histological analysis. The experimental protocol was
approved by the Ethics Committee for animal research of the
Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil and
followed theNIHGuide for the Care andUse of Laboratory Animals (NIH
publication 85–23, revised 1985). All effortsweremade tominimize the
number of animals used and their suffering.
In the experiments designed to evaluate the participation of NMDA-
glutamate receptors, the animals received MK-801 (0.25 mg/kg, i.p.) orNaCl (0.9%, 10 mL/kg, i.p.) 30 min before Gly injection (Ribeiro et al.,
2006).
Striatum preparation
The rats were sacriﬁced by decapitation without anesthesia 2 or
12 h after intrastriatal injection of either Gly or NaCl. The brain was
rapidly excised on a Petri dish placed on ice. The olfactory bulb, pons,
medulla, cortex, and cerebellumwere discarded, and the striatumwas
dissected, weighed, and homogenized in 10 volumes (1:10, w/v) of
20 mM sodium phosphate buffer, pH 7.4 containing 140 mM KCl.
Homogenates were centrifuged at 750 ×g for 10 min at 4 °C to discard
nuclei and cell debris (Evelson et al., 2001). The pellet was discarded
and the supernatant, a suspension of mixed and preserved organelles,
includingmitochondria, was separated and used tomeasure oxidative
stress parameters.
Thiobarbituric acid-reactive substances (TBA-RS)
TBA-RS levels were measured according to the method described
by Yagi (1998) with slight modiﬁcations. Brieﬂy, 200 μL of 10%
trichloroacetic acid and 300 μL of 0.67% TBA in 7.1% sodium sulfate
were added to 100 μL of tissue supernatants containing 0.3 mg of
protein and incubated for 2 h in a boiling water bath. Themixture was
allowed to cool on running tap water for 5 min. The resulting pink-
stained complex was extracted with 400 μL of butanol. Fluorescence
of the organic phase was read at 515 nm and 553 nm as excitation and
emission wavelengths, respectively. Calibration curve was performed
using 1,1,3,3-tetramethoxypropane and subjected to the same
treatment as supernatants. TBA-RS levels were calculated as nmol
TBA-RS/mg protein.
Protein carbonyl formation
Protein carbonyl formation, a marker of protein oxidative damage,
was measured spectrophotometrically according to Reznick and
Packer (1994). Two hundred microliters of striatum supernatants
containing 0.3 mg of protein were treated with 400 μL of 10 mM
2,4-dinitrophenylhidrazine (DNPH) dissolved in 2.5 N HCl or with
2.5 N HCl (blank) and left in the dark for 1 h. Samples were then
precipitated with 600 μL 20% TCA and centrifuged for 5 min at
10,000 g. The pellet was thenwashedwith 1 mL ethanol: ethyl acetate
(1:1, V/V) and suspended in 550 μL 6 M guanidine prepared in 2.5 N
HCl at 37 °C for 5 min. The difference between the DNPH-treated and
HCl-treated samples (blank) was used to calculate the carbonyl
content determined at 365 nm. The results were calculated as nmol of
carbonyl groups/mg of protein, using the extinction coefﬁcient of
22,000×106 nmol/mL for aliphatic hydrazones.
Nitrate and nitrite formation
Nitrite oxide production was determined by measuring nitrate
(NO3−) and nitrite (NO2−) according to Miranda et al. (2001). Two
hundred microliters of vanadium chloride was added to the tube
containing 200 μL of striatal supernatants (0.3 mg of protein) for
complete reduction of nitrate to nitrite. Then, 200 μL of Griess reagent
(a mixture of N-1-naphtylethylenediamine dihydrochloride and sulfa-
nilamide) was added, and the tube was incubated for 30 min at 37 °C in
a water bath in a dark room. The resulting pink-stained pigment was
determined in a spectrophotometer at 540 nm. A calibration curve was
performed using sodium nitrate (2.5, 5, 10, 15, 25, 50 and 100 μM), and
each curve point was subjected to the same treatment as supernatants.
Nitric oxide production values were calculated as nmol/mg protein and
represented as percentage of control.
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Fig. 1. Effect of intrastriatal administration of glycine (Gly, 4 μmol) on thiobarbituric
acid-reactive substances (TBA-RS) levels in rat striatum 2 h after injection. Data are
expressed as mean±SD for 5–6 independent experiments (animals) performed in
triplicate. ***Pb0.001, compared to rats that received intrastriatal NaCl injection
(Student's t-test for unpaired samples).
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This assay is basedon the reductionof 5-5-dithio-bis (2-nitrobenzoic
acid) (DTNB) by thiols, generating a yellow derivative (TNB) whose
absorption is measured spectrophotometrically at 412 nm (Aksenov
andMarkesbery, 2001). Brieﬂy, 30 μL of 10 mMDTNB and 980 μL of PBS
were added to 50 μL of striatum supernatants containing 0.3 mg of
protein. Thiswas followedby30 min incubation at room temperature in
a dark room. Absorptionwasmeasured at 412 nm. Sulfhydryl content is
inversely correlated to oxidative damage to proteins. Results were
reported as nmol/mg protein.
Reduced glutathione (GSH) levels
GSH levels were measured according to Browne and Armstrong
(1998). Tissue supernatants with approximately 0.3 mg of proteinwere
diluted in 20 volumes (1:20, v/v) of 100 mM sodium phosphate buffer
pH 8.0, containing 5 mM EDTA. One hundred microliters of this
preparationwas incubatedwith an equal volume of o-phthaldialdehyde
(1 mg/mLmethanol) at room temperature for 15 min. Fluorescencewas
measured using excitation and emission wavelengths of 350 nm and
420 nm, respectively. Calibration curve was performed with standard
GSH (0.001–0.1 mM), andGSH concentrationswere calculated as nmol/
mg protein.
Glutathione peroxidase (GPx) activity
GPx activity was measured according to Wendel (1981) using tert-
butylhydroperoxide as substrate. The enzyme activity was determined
by monitoring the NADPH disappearance at 340 nm in a medium
containing 100 mM potassium phosphate buffer/1 mM ethylenediami-
netetraacetic acid, pH 7.7, 2 mM GSH, 0.1 U/mL glutathione reductase,
0.4 mM azide, 0.5 mM tert-butyl-hydroperoxide, 0.1 mM NADPH and
approximately 3 μg of protein. One GPx unit (U) is deﬁned as 1 μmol of
NADPH consumed perminute. The speciﬁc activity was calculated as U/
mg protein.
Glutathione reductase (GR) activity
GRactivitywasmeasured according toCalberg andMannervik (1985)
using oxidized glutathione (GSSG) andNADPHas substrates. The enzyme
activity was determined by monitoring the NADPH disappearance at
340 nm in a medium with 200 mM sodium phosphate buffer, pH 7.5,
containing 6.3 mMethylenediaminetetraacetic acid, 1 mMGSSG, 0.1 mM
NADPH and approximately 3 μg of protein. One GR unit (U) is deﬁned as
1 μmolofGSSG reducedperminute. The speciﬁc activitywas calculatedas
U/mg protein.
Catalase (CAT) activity
CAT activity was assayed according to Aebi (1984) bymeasuring the
absorbance decrease at 240 nm in a reactionmediumcontaining20 mM
H2O2, 0.1% Triton X-100, 10 mM potassium phosphate buffer, pH 7.0,
and approximately 1 μgof protein.Oneunit (U) of the enzyme is deﬁned
as 1 μmol of H2O2 consumed per minute. The speciﬁc activity was
calculated as U/mg protein.
Superoxide dismutase (SOD) activity
SOD activity was assayed according to Marklund (1985) and is
based on the capacity of pyrogallol to autooxidize, a process highly
dependent on O2•−, which is a substrate for SOD. The inhibition of
autoxidation of this compound occurs in the presence of SOD, whose
activity can be then indirectly assayed spectrophotometrically at
420 nm. The reaction medium contained 50 mM Tris buffer/1 mM
ethylenediaminetetraacetic acid, pH 8.2, 80 U/mL catalase, 0.38 mMpyrogallol and approximately 1 μg of protein. A calibration curve was
performed with puriﬁed SOD as a standard to calculate the activity of
SOD present in the samples. The results are reported as U/mg protein.
Glucose-6-phosphate dehydrogenase (G6PD) activity
G6PD activity was measured by the method of Leon and Clark
(1984), in a reaction mixture (1 mL) containing 100 mM Tris–HCl pH
7.5, 10 mMMgCl2, 0.5 mM NADP+ and approximately 3 μg of protein.
The reaction was started by the addition of 1 mM glucose-6-phosphate
and was followed in a spectrophotometer at 340 nm. One G6PD unit
corresponds to 1 mmol of substrate transformed per minute and the
speciﬁc activity is represented as units per mg protein.
Protein determination
Protein levels weremeasured by themethod of Lowry et al. (1951)
using bovine serum albumin as standard.
Statistical analysis
Results are presented as mean±standard deviation. Assays were
performed in triplicate and the mean was used for statistical
calculations. Data were analyzed using the Student's t test for unpaired
samples or one-way analysis of variance (ANOVA) followed by the
Duncan multiple range test when the F value was signiﬁcant. Only
signiﬁcant values are shown in the text. Differences between groups
were rated signiﬁcant atPb0.05.All analyseswere carriedout in an IBM-
compatible PC computer using the Statistical Package for the Social
Sciences (SPSS) software.
Results
Gly intrastriatal administration induces lipid peroxidation
Initially we studied the effect of intrastriatal injection of 4 μmol Gly
on TBA-RS levels 2 h after drug infusion. Fig. 1 shows that Gly
administration induced lipidperoxidation (TBA-RS increase) in striatum
[t(8)=6.334; Pb0.001] as compared to rats that received NaCl. We also
observed that intraperitoneal injection of theNMDAantagonistMK-801
(0.25 mg/kg) 30 min prior to Gly administration fully prevented the
increase of TBA-RS levels caused by this amino acid [F(3,19)=22.14;
Pb0.001] (Fig. 2). These results indicate that the lipid peroxidation
caused by Gly administration was probably mediated by NMDA
overstimulation.
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Fig. 2. Effect of MK-801 on the increased thiobarbituric acid reactive substances (TBA-RS)
levels caused by glycine (Gly, 4 μmol) intrastriatal injection. Animals were pre-treated
with saline orMK-801 i.p. 30 min prior to glycine (Gly, 4 μmol) injection and sacriﬁced 2 h
later. Data are represented as mean±SD for 5–6 independent experiments (animals)
performed in triplicate. ***Pb0.001 compared to rats pre-treated with saline and treated
with NaCl; ###Pb0.001 compared to rats pre-treated with saline and treated with Gly
(ANOVA followed by Duncan's multiple range test).
Table 1
Effect of glycine intrastriatal administration (Gly, 4 μmol) on nitrate and nitrite
production, sulfhydryl content and reduced glutathione (GSH) levels in rat striatum 2 h
after injection.
Treatment
NaCl Gly
Nitrates and nitrites 4.90±0.20 4.70±0.17
Sulfhydryl 89.8±6.93 91.2±4.30
GSH 13.1±0.77 12.6±0.88
Data are represented as mean±SD for 5 independent experiments (animals). No
signiﬁcant differences were found between groups (Student's t-test for unpaired
samples). Results are expressed as nmol/mg protein.
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Fig. 3 shows that Gly provoked a marked increase of carbonyl
formation 2 h after Gly injection [t(8)=3.052; Pb0.05], implying that
protein oxidative damage was caused by this amino acid.
Gly intrastriatal administration does not alter nitrate and nitrite
formation, sulfhydryl content and glutathione (GSH) levels
We also investigated the effect of Gly administration on nitrate and
nitrite production, sulfhydryl content and GSH concentrations in rat
striatum. It can be observed in Table 1 that Gly injection did not
modify these parameters 2 h after its infusion.
Gly intrastriatal administration increases glutathione peroxidase (GPx),
glutathione reductase (GR), catalase (CAT) and superoxide dismutase
(SOD) activities
We investigated the effect of Gly intrastriatal administration on
the activities of GPx, GR, CAT, SOD and G6PD in striatum of young rats.
Our results demonstrate that a single Gly injection signiﬁcantly
increased GPx [t(7)=6.663; Pb0.001], GR [t(10)=12.44; Pb0.001],
CAT [t(7)=2.556; Pb0.05] and SOD [t(7)=2.526; Pb0.05] 12 h after
the administration, whereas G6PD activity was not changed (Fig. 4).
Discussion
The pathogenetic mechanisms involved in the severe cerebral
damage of patients with NKH are insufﬁciently understood. However,0
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Fig. 3. Effect of intrastriatal administration of glycine (Gly, 4 μmol) on protein carbonyl
formation in rat striatum at 2 h after injection. Data are represented as mean±SD for 5
independent experiments (animals). ***Pb0.001, compared to rats that received
intrastriatal NaCl injection (Student's t-test for unpaired samples).it is likely that excitotoxicity is involved at least in part in the
neuropathology of this disorder since Gly is a co-agonist of NMDA
receptors (McNamara and Dingledine, 1990; Patel et al., 1990; Hara
et al., 1993; Kure et al., 1997; Katsuki et al., 2007; Kono et al., 2007;
Kikuchi et al., 2008). On the other hand, considering that normal Gly
values in human body ﬂuids are sufﬁciently high to saturate the binding
site for Gly on the NMDA-type glutamate receptors, it is feasible that
higher concentrations of Gly may not cause overstimulation of these
receptors (Obrenovitcha et al., 1997). Thus, other mechanisms may
underlie brain damage in NKH. In this scenario, it has been recently
demonstrated thatGly induces oxidative stress and compromises energy
metabolism in vitro in rat brain, although the mechanisms underlying
these effects were not elucidated (Leipnitz et al., 2009; Busanello et al.,
2010). Therefore, it seems that more research, particularly in vivo
studies, is required to clarify themechanisms causing neuronal death in
patients with NKH.
In the present report we investigated whether an acute intras-
triatal injection of Gly could induce oxidative damage and/or alter the
main antioxidant defenses in striatum of young rats.We observed that
Gly in vivo administration signiﬁcantly increased TBA-RS levels in the
striatum, corroborating our previous in vitro ﬁndings (Leipnitz et al.,
2009). Since TBA-RS measurement reﬂects the amount of malondial-
dehyde formation, an end product of membrane fatty acid peroxida-
tion (Halliwell and Gutteridge, 2007), our present ﬁndings indicate
that Gly provoked lipid oxidative damage in vivo. We also showed
that the non-competitive NMDA receptor antagonist MK-801 pre-
vented the increase of TBA-RS levels elicited by Gly, implying the
involvement of the NMDA receptor in this effect. Our present ﬁndings
are in accordance with previous studies demonstrating a prevention
of Gly-induced degeneration in rat striatum caused by MK-801 and
suggest that oxidative damage may underlie this neurodegeneration
(Santamaría and Ríos, 1993; Jara-Prado et al., 2003).
Gly also markedly increased carbonyl formation after intrastriatal
administration. Since carbonyl group generation is currently used as a
marker of free radical-mediated protein oxidation (Levine et al.,
1994), especially on amino acid side chain residues (Pro, Arg, Lys, and
Thr) (Dalle-Donne et al., 2003), it is presumed that Gly induced
protein oxidative damage in striatum.
In contrast, Gly did not alter GSH levels and sulfhydryl content in the
striatum Endogenous GSH is the main naturally-occurring antioxidant
in the brain and is used to evaluate the non-enzymatic antioxidant
capacity of a tissue to prevent the damage associated to free radical
processes (Halliwell and Gutteridge, 2007). On the other hand,
approximately two thirds of sulfhydryl groups are bound to proteins,
whereas one third is a component of small molecules such as GSH
(Requejo et al., 2010). Furthermore, since protein-bound sulfhydryl
groups (PBSG) can be reversibly oxidized by reactive species, it has been
suggested that PBSG represent a potential active redox antioxidant pool
in the cellular defense against oxidative stress (Thomas et al., 1995;
Hansen et al., 2009). Taken together, our present data indicate that rat
striatal non-enzymatic antioxidant defenses were not modiﬁed by Gly
(Lissi et al., 1995; Halliwell and Gutteridge, 2007).
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Fig. 4. Effect of intrastriatal administration of glycine (Gly, 4 μmol) on the activity of the enzymes glutathione peroxidase (GPx; A), glutathione reductase (GR; B), catalase (CAT; C),
superoxide dismutase (SOD; D) and glucose-6-phosphate dehydrogenase (G6PD; E) in rat striatum 12 h after injection. Data are represented as mean±SD for 5 independent
experiments (animals). *Pb0.05; **Pb0.01***Pb0.001, compared to rats that received intrastriatal NaCl injection (Student's t-test for unpaired samples).
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GR, CAT and SOD activities were signiﬁcantly increased after 12 h of
Gly intrastriatal administration. In this context, it is widely known
that reactive species may regulate the expression of numerous genes
via signaling mechanisms (Rushmore et al., 1991; Lakshminarayanan
et al., 1998; Halliwell and Gutteridge, 2007). It is therefore
conceivable that induction of the expression of these endogenous
antioxidant enzymes (GPx, GR, CAT and SOD) at the gene level might
have taken place as a compensatory mechanism in response to
increased formation of reactive species. Furthermore, considering that
SOD scavenges superoxide anions (Fridovich, 1989), whereas GPx and
CAT scavenge preferentially fatty acid hydroperoxides and H2O2
(Shull et al., 1991; Matés et al., 1999), we presume that these reactive
species were elicited by Gly administration. This is in line with our
ﬁndings showing that Gly did not increase nitrate and nitrite
formation, signaling that Gly-induced lipid and protein oxidative
damage probably occurred via reactive oxygen species (ROS).
On the other hand, it is possible that a higher GR activity may
explain the normal GSH concentrations found in the present study
despite the increase of GPx activity. Similar ﬁndings showing normal
GSH levels with a higher activity of GPxwere observed in brainstem of
hypoglycemic rats (Singh et al., 2004).
We emphasize that, although Gly induced lipid oxidative damage
probably as a consequence of overstimulation of NMDA receptors, we
cannot exclude the possibility that this amino acid also caused the
generation of free radicals via other mechanisms, as previously
demonstrated in vitro (Leipnitz et al., 2009).
At this point it should be emphasized that the brain has low
cerebral antioxidant defenses compared with other tissues (Halliwell,
1992), a fact that makes this tissue more vulnerable to increased
formation of reactive species (Halliwell, 1992). The lower capacity of
the brain to react against free radicals is reinforced by the fact that this
tissue has a high rate of oxidative metabolism coupled to ROS
production, high amount of iron and higher peroxidation potential
because of its high content of polyunsaturated fatty acids (Halliwell
and Gutteridge, 2007).
It is difﬁcult to determine the pathophysiological relevance of our
present data. However, considering that brain Gly concentrations inNKH-affected patients are at the millimolar range and that Gly-pro-
oxidant effects occurred at these concentrations, it is feasible that our
results might contribute, at least in part, to explain the brain damage
found in patients affected by NKH.
Conclusion
We report for the ﬁrst time that Gly induces oxidative stress in vivo
in the striatum. It is presumed that overproduction of reactive radicals
due to high brain Gly concentrations is potentially deleterious to the
CNS and may represent a relevant pathomechanism of brain injury in
NKH and other pathologies with high Gly concentrations.
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